• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强型并行把关策略的应用

The application of enhanced parallel gatekeeping strategies.

作者信息

Chen Xun, Luo Xiaohui, Capizzi Tom

机构信息

Clinical Biostatistics, Merck Research Laboratories, RY34-A316, Rahway, NJ 07065, USA.

出版信息

Stat Med. 2005 May 15;24(9):1385-97. doi: 10.1002/sim.2005.

DOI:10.1002/sim.2005
PMID:15568191
Abstract

The parallel gatekeeping strategy proposed by Dmitrienko et al. (Statist. Med. 2003; 22:2387-2400) provides a flexible framework for the pursuit of strong control on study wise type I error rate. This paper further explores the application of the weighted Simes parallel gatekeeping procedure recommended by Dmitrienko et al. and proposes some modifications to it to better incorporate the interrelationships of different hypotheses in actual clinical trials and to achieve better power performance. We first propose a simple method to quantitatively control the impact of secondary tests on the testing of primary hypotheses. We then introduce a matched gatekeeping procedure to exemplify how to address special relationships between individual primary and secondary tests following the parallel gatekeeping framework. Our simulation study demonstrates that the enhanced gatekeeping procedures generally result in more powerful tests than the parallel gatekeeping procedure in Dmitrienko et al. whenever applicable.

摘要

德米特里延科等人(《统计医学》,2003年;22:2387 - 2400)提出的平行把关策略为严格控制研究层面的I型错误率提供了一个灵活的框架。本文进一步探讨了德米特里延科等人推荐的加权西姆斯平行把关程序的应用,并对其提出了一些修改建议,以便在实际临床试验中更好地纳入不同假设之间的相互关系,并实现更好的检验效能表现。我们首先提出一种简单的方法来定量控制次要检验对主要假设检验的影响。然后我们引入一种匹配把关程序,以举例说明如何在平行把关框架下处理各个主要和次要检验之间的特殊关系。我们的模拟研究表明,在适用的情况下,增强后的把关程序通常比德米特里延科等人提出的平行把关程序具有更强的检验效能。

相似文献

1
The application of enhanced parallel gatekeeping strategies.增强型并行把关策略的应用
Stat Med. 2005 May 15;24(9):1385-97. doi: 10.1002/sim.2005.
2
Multistage and mixture parallel gatekeeping procedures in clinical trials.临床试验中的多阶段和混合平行把关程序。
J Biopharm Stat. 2011 Jul;21(4):726-47. doi: 10.1080/10543406.2011.551333.
3
A Dunnett-Bonferroni-based parallel gatekeeping procedure for dose-response clinical trials with multiple endpoints.一种基于邓尼特-邦费罗尼法的用于多终点剂量反应临床试验的平行把关程序。
Pharm Stat. 2009 Oct-Dec;8(4):301-16. doi: 10.1002/pst.358.
4
A note on tree gatekeeping procedures in clinical trials.关于临床试验中树状把关程序的说明。
Stat Med. 2008 Jul 30;27(17):3446-51. doi: 10.1002/sim.3307.
5
Gatekeeping strategies for clinical trials that do not require all primary effects to be significant.针对不需要所有主要效应都具有显著性的临床试验的把关策略。
Stat Med. 2003 Aug 15;22(15):2387-400. doi: 10.1002/sim.1526.
6
Comparison of gatekeeping and other testing methods for identifying superior drug combinations in bifactorial designs with isotonic parameters.在具有等渗参数的双因素设计中,守门法与其他用于识别优质药物组合的测试方法的比较。
J Biopharm Stat. 2011 Jul;21(4):635-49. doi: 10.1080/10543406.2011.551328.
7
Multiplicity adjustment for multiple endpoints in clinical trials with multiple doses of an active treatment.多剂量活性治疗的临床试验中多个终点的多重性调整。
Stat Med. 2005 Jul 30;24(14):2151-70. doi: 10.1002/sim.2101.
8
A note on non-parametric ANCOVA for covariate adjustment in randomized clinical trials.关于随机临床试验中用于协变量调整的非参数协方差分析的注释
Stat Med. 2003 Dec 15;22(23):3583-96. doi: 10.1002/sim.1583.
9
Mixtures of multiple testing procedures for gatekeeping applications in clinical trials.临床试验中门控应用的多重检验程序混合。
Stat Med. 2011 Jun 15;30(13):1473-88. doi: 10.1002/sim.4008. Epub 2011 Apr 18.
10
Powerful short-cuts for multiple testing procedures with special reference to gatekeeping strategies.多重检验程序的强大捷径,特别提及把关策略。
Stat Med. 2007 Sep 30;26(22):4063-73. doi: 10.1002/sim.2873.

引用本文的文献

1
A gated group sequential design for seamless Phase II/III trial with subpopulation selection.具有亚组选择的无缝二期/三期试验的门控分组序贯设计。
BMC Med Res Methodol. 2023 Jan 3;23(1):2. doi: 10.1186/s12874-022-01825-0.
2
Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 study.卡利拉嗪治疗双相 I 型抑郁症的疗效和安全性:一项双盲、安慰剂对照的 3 期研究。
Bipolar Disord. 2020 Jun;22(4):372-384. doi: 10.1111/bdi.12852. Epub 2019 Nov 6.
3
Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
卡立普嗪辅助治疗重度抑郁症:一项随机、双盲、安慰剂对照试验的结果
Psychopharmacol Bull. 2018 Jun 20;48(4):62-80.
4
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder.一项评估维拉佐酮治疗青少年重性抑郁障碍的 3 期、双盲、随机、安慰剂对照研究。
Paediatr Drugs. 2018 Aug;20(4):353-363. doi: 10.1007/s40272-018-0290-4.
5
A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorder.一项关于维拉唑酮治疗广泛性焦虑症患者的双盲、随机、安慰剂对照、固定剂量的III期研究。
Depress Anxiety. 2015 Jun;32(6):451-9. doi: 10.1002/da.22365. Epub 2015 Apr 17.
6
Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial.伏硫西汀20毫克和40毫克治疗重度抑郁症的疗效与安全性:一项随机、双盲、安慰剂对照试验
Int Clin Psychopharmacol. 2015 Mar;30(2):67-74. doi: 10.1097/YIC.0000000000000057.
7
Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests.使用加权邦费罗尼法、西姆斯法或参数检验进行多重比较程序的图形方法。
Biom J. 2011 Nov;53(6):894-913. doi: 10.1002/bimj.201000239. Epub 2011 Aug 12.